Sign in

Cystic fibrosis

Current status: Treatable, not yet curable

An inherited condition that makes the body produce thick, sticky mucus, which can affect the lungs and the digestive system. Common signs are a lasting cough with mucus, frequent chest infections and, in children, slow growth. There is no cure yet, but medicines, physiotherapy and diet support can help. A child gets it only when both parents pass on the altered gene, and many people diagnosed today are expected to live well past middle age.

Read more about cystic fibrosis
Where research stands todayUpdated 18 Nov 2026

Trial-stage treatments and research studies you can joinOpen trials for referral

Registry data only. Frontlight does not judge whether a patient can take part: the trial team decides.

Filters

Country
City
Distance is calculated in your browser. Your city is not sent to us.
Type
Get notified of new trialsLithuania, all cities, all phases
Your ageShows only trials that take people your age.
Phase
  1. Trial-stage treatmentPhase 2Soon in Lithuania
    Tests inhaled SPL84 in adults with cystic fibrosis and a specific gene mutation

    Tests whether inhaled SPL84 is safe and may help adults with cystic fibrosis.

    Kaunas, LithuaniaAge 18+
  2. Trial-stage treatmentPhase 2Taking people
    Tests inhaled SPL84 for safety in people with cystic fibrosis

    Tests an inhaled medicine, SPL84, for safety in adults with cystic fibrosis.

    Kaunas, LithuaniaAge 18+

Search the publications

The results open on the publications page in a new tab, so this page stays as it is.

Lists with this disease filtered

Where treatment stands

There is no cure yet, but treatment can often manage the symptoms, and many people diagnosed today will live well past middle age.

Approved: 22

Officially approved for this disease in the EU, the US, Switzerland or France.

Human testing stage: 4

Being tested in people. Many treatments at this stage are never approved.

Support organisations

Patient organisations and helplines in Lithuania, for you and your family.

We have no organisations for this disease listed in Lithuania yet. General support there is below.

General support in Lithuania

  • Vilties linija – suaugusiųjų emocinė parama 116123

    Lithuania's national 24/7 emotional support line for adults on the EU number 116123.

Frontlight Community

Cystic fibrosis community in Lithuania

People living with cystic fibrosis and those close to them share what they went through. Posts are not medical advice: ask your doctor about your own treatment.

Offer tissue or data

There are three ways to help research move faster.

Give tissue or bloodA biobank stores your sample so many research teams can use it.No open programme yet
Share your health dataA patient registry collects your health data, without your name, for research.How to join
Take part as a healthy volunteerStudies also need people without the disease, for comparison. Family and friends can help.Volunteer

Approved treatments

23 medicines are approved for cystic fibrosis in at least one of the places we checked. An approval in one place does not mean the medicine is offered or paid for where you live.

Checked on 18 Nov 2026 in the official lists of the US (FDA), the EU (European Commission and EMA) and Switzerland (Swissmedic), which we read every day. The lists of Japan (PMDA, approvals since April 2004), France (ANSM, medicines approved in France only) and Taiwan (TFDA) were checked on 11 Nov 2026. For Canada (Health Canada) and Singapore (HSA) we checked only whether a medicine is sold there, not what for. The French ratings are the opinions of the HAS Transparency Committee, from the French public medicines database (base de données publique des médicaments, newest opinion 10 Dec 2025). 2 uncertain matches are left out. Other countries' own approvals were not checked.

“Miracle cure” fact checker

Social media spreads misinformation. Paste here what you read, and we'll tell you whether there is scientific evidence behind it.

What you paste is checked with AI (Anthropic, USA) and is not stored. Please leave out names and other personal details.

Before you pay for anything, ask three things

  1. Is there a published study in people?
  2. Can I have the full price in writing?
  3. What does my doctor say?

About cystic fibrosis

Sources: NHS, MedlinePlus, Journal of Cystic Fibrosis

An inherited condition that makes the body produce thick, sticky mucus, which can affect the lungs and the digestive system. Common signs are a lasting cough with mucus, frequent chest infections and, in children, slow growth. There is no cure yet, but medicines, physiotherapy and diet support can help. A child gets it only when both parents pass on the altered gene, and many people diagnosed today are expected to live well past middle age.

What is it?

Cystic fibrosis (CF) is a rare inherited condition. The body makes thick, sticky mucus that can affect the lungs and the digestive system and makes infections more likely. It mostly affects the lungs, the pancreas, the liver, the gut, the sinuses and the sex organs.

A child gets CF only when both parents pass on an altered gene. Someone who gets the gene from just one parent usually has no symptoms but is a carrier. When two carriers have a child, there is a 1 in 4 chance that the child has CF. If you have CF or are a carrier, you can ask for genetic counselling before having a baby.

The first signs

Most babies are now found through newborn screening.

  • a cough that does not go away and brings up mucus;
  • wheezing and shortness of breath;
  • frequent chest and sinus infections;
  • large, greasy poos that are hard to flush, constipation, tummy pain or bloating;
  • slow growth in children, or weight loss in adults;
  • very salty sweat.

Some people have a milder form that does not show until the teenage years or early adulthood.

How doctors find out

All babies are checked for cystic fibrosis with the newborn blood spot test. If it suggests CF, a sweat test measures the salt in the sweat, which is usually high in CF. Older children and adults have a blood test and then a sweat test. Relatives of someone with CF, and partners of carriers, can have a test to see if they are carriers.

Current treatment

Care from a specialist CF team combines CFTR modulator medicines, airway-clearing medicines and physiotherapy, antibiotics for infections and a high-energy diet, with a lung transplant for some.

Will it get worse?

CF needs care for life and can shorten life. Over time it can lead to lung damage and other problems such as diabetes, liver disease, weak bones and difficulty having children, and many of these can be treated. Thanks to newer treatments many symptoms can be managed, and many people diagnosed today are expected to live well past middle age.

Medicines: what helps, and what to watch for

CFTR modulators are medicines that lessen the effect of the altered gene, so the lungs work better. Other medicines open up the airways or help clear mucus, antibiotics treat infections, and steroids calm swelling in the airways. Devices such as inhalers and specially designed masks can help with breathing and clearing mucus.

Good to know:

  • you are cared for by a CF team, usually based at a larger hospital, with specialist doctors and nurses, a physiotherapist and a dietitian;

Exercise and therapy help too

  • a physiotherapist can teach you ways to improve your breathing and posture, which helps clear mucus from your lungs;
  • staying active also helps clear mucus;

A lung transplant, for some people

If other treatments stop working, some people may in time need a lung transplant. It is not suitable for everyone.

Is there a cure?

Not yet. Treatments have improved greatly in recent years, and gene editing shows promise.

See the 198 trials you can join

Median survival

Median survival age at birth about 46 years (males) and 41 years (females), UK data 2011–2015

Measured in: People in the UK Cystic Fibrosis Registry, 2011–2015 (10,428 people); survival age counted from birth

The figures behind it

UK Cystic Fibrosis Registry data, 2011–2015 (10,428 people, 602 deaths): median survival age at birth 46 years for males and 41 years for females with two copies of F508del, similar for others diagnosed at birth. If mortality keeps improving at the same rate, the projection is 65 (males) and 56 (females).